Skip to main content
. 2018 Apr 26;57(8):1390–1399. doi: 10.1093/rheumatology/key104

Fig. 2.

Fig. 2

Relationship between patients achieving MIC for SPARCC SI joint score and clinical responses at week 12

Clinical responses measured by (A) ASAS20, (B) ASAS40, (C) ASDAS MI, (D) ASDAS CII, (E) ASDAS ID and (F) ASDAS moderate disease activity. Statistical analysis for the pooled 5 and 10 mg BID group using Fisher’s exact test showed no significant association between MIC and any clinical response SI joint ≥MIC (2.5): patients achieving the MIC for SPARCC SI joint score (≥2.5-point decrease) SI joint <MIC (2.5): patients not achieving the MIC for SPARCC SI joint score (<2.5-point decrease). ASAS: Assessment of SpondyloArthritis international Society; BID: twice daily; CII: clinically important improvement; ID: inactive disease; MI: major improvement; MIC: minimally important change; n: number of patients achieving/not achieving MIC; SPARCC: SPondyloArthritis Research Consortium of Canada.